Cargando…
Human neural stem cell transplantation in ALS: initial results from a phase I trial
BACKGROUND: We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, fetal human neural stem cells from natural in utero death (hNSCs) into the anterior horns of the spinal cord to test for the safety of both cells and neurosurgical procedures in these patients...
Ejemplares similares
-
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long‐Term Outcome
por: Mazzini, Letizia, et al.
Publicado: (2019) -
Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization
por: Profico, Daniela Celeste, et al.
Publicado: (2022) -
Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats
por: Zalfa, Cristina, et al.
Publicado: (2019) -
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies
por: Rosati, Jessica, et al.
Publicado: (2018) -
Misophonia: Analysis of the neuroanatomic patterns at the basis of psychiatric symptoms and changes of the orthosympathetic/ parasympathetic balance
por: Grossini, Elena, et al.
Publicado: (2022)